When a Normal Lipid Panel Is Not Reassuring

I had a 44-year-old runner last week — normal lipid panel, low ten-year ASCVD risk, father stented at 52. He wanted reassurance. I wasn't sure I could give it.

You were right to hesitate. The pooled cohort equations answer one question: what is the probability of a clinical event in the next ten years? They are not designed to tell you how much plaque is already there.

So the calculator is fine, it's just the wrong tool for what he's actually asking?

Exactly. Atherosclerosis is cumulative particle exposure — the number of apoB-containing particles circulating, multiplied by the years they've been doing so. A 44-year-old with modest LDL-C has had two decades of exposure the calculator doesn't see.

ApoB — that's the protein on every atherogenic particle, one per particle, so it's a direct count rather than an estimate of cargo?

Right. LDL-C tells you how much cholesterol is inside LDL particles. ApoB tells you how many particles are there. In a patient with high HDL and mid-range triglycerides, LDL-C routinely underestimates particle number. The ACC and ESC both now support apoB as a better risk marker than LDL-C — that's guideline level, not experimental.

What's the threshold I'm targeting?

For primary prevention, an apoB above 100 milligrams per decilitre warrants attention. Above 130 is elevated by any major guideline. But don't stop there — order Lp(a) once in every patient's lifetime.

Lp(a) — that's lipoprotein little-a, a separate particle with its own independent risk?

It's an LDL-like particle with an additional protein called apolipoprotein(a) attached, and it's almost entirely genetically determined. Above roughly 50 milligrams per decilitre, it confers independent atherosclerotic and thrombotic risk. One in five people carry a significant level and most don't know it.

His father's early disease — does that change the math here?

First-degree relative with coronary disease before 55 in a man is a risk enhancer in ACC-AHA 2019 guidelines. It should push you toward imaging rather than watchful waiting.

Which imaging? Stress test, CTA?

Coronary artery calcium scoring — a low-dose CT with no contrast, no stress, scored in Agatston units. A CAC of zero in a 44-year-old is genuinely reassuring and supports deferring statins. A CAC above 100, or above the 75th percentile for age and sex, tips the decision toward starting therapy. That's ACC-AHA guideline-supported.

And if his apoB is elevated and his CAC is above 100, I'm treating even though his ten-year risk number is low?

Yes. The number is low because he is young, not because his arteries are healthy. High-intensity statin, target apoB below 80. If Lp(a) is also elevated, that's a conversation about emerging therapies — but no approved Lp(a)-specific drug exists yet for primary prevention outside trials.

What's the one thing you'd want me to walk out with?

A normal LDL-C with a family history is an incomplete sentence. Finish it with apoB, Lp(a), and a CAC score. Those three together will tell you whether this runner's arteries match his fitness, or whether they've been quietly accumulating exposure for twenty years.